Understanding Oncogene Signaling and
We seek to understand how oncogenes reprogram cancer cells to drive cancer heterogeneity and metastasis.
We seek to understand the emergent properties of complex collections of tumor cells that self-assemble to cause therapy resistance and metastasis.
We seek to understand new cancer vulnerabilities to eliminate metastasis.
We focus on therapies that target metabolic programs, cell cycle and anti-cancer immune programs.
We seek to understand the emergent properties of complex collections of tumor cells that self-assemble to cause therapy resistance and metastasis.
We seek to understand new cancer vulnerabilities to eliminate metastasis.
We focus on therapies that target metabolic programs, cell cycle and anti-cancer immune programs.
Latest News
Opportunity: We are recruiting motivated graduate students interested in cancer metastasis, how oncogenes alter metabolism and the cell cycle, and the discovery of new anti-metastatic therapies.
Graduation: June, 2026 - Dr. Daphne Superville will complete her PhD in the UCSF BMS Program. Her major work on immune regulation and metastasis vulnerabilities is forthcoming.
Graduation: March, 2026 - Dr. Mauricio Jacobo Jacobo - completed his PhD in the PSPG program. His work on Mitotic Vulnerabilities in Triple Negative Breast Cancer is currently being completed for publication.
Graduation: January 2025 - Dr. Jeremy Williams - completed his PhD in the UCSF BMS program. His major studies were published on how breast tumor cells and adipocytes interact via CX31 gap junctions in Nature Comm.
Graduation: September, 2024 - Congratulations, Dr. Ton Montoya, who defended his thesis. Also published his fantastic work describing a new role for alanine metabolism in MYC-driven cancers.
Graduation: June, 2024 - Congratulations, Laurine Idoux, Masters Student from University of Paris, completed studies on oxygen-dependent cancer metabolism and role in metastasis, working closely with and mentored by Daphne Superville.
New Grant: September, 2024 - Excited to start work on a newly funded NIH R01 (MPI) with Dr. Nimmi Ramanujam and her team. Goal is to develop technology for improved spatial analysis of cancer metabolism.
Graduation: June, 2026 - Dr. Daphne Superville will complete her PhD in the UCSF BMS Program. Her major work on immune regulation and metastasis vulnerabilities is forthcoming.
Graduation: March, 2026 - Dr. Mauricio Jacobo Jacobo - completed his PhD in the PSPG program. His work on Mitotic Vulnerabilities in Triple Negative Breast Cancer is currently being completed for publication.
Graduation: January 2025 - Dr. Jeremy Williams - completed his PhD in the UCSF BMS program. His major studies were published on how breast tumor cells and adipocytes interact via CX31 gap junctions in Nature Comm.
Graduation: September, 2024 - Congratulations, Dr. Ton Montoya, who defended his thesis. Also published his fantastic work describing a new role for alanine metabolism in MYC-driven cancers.
Graduation: June, 2024 - Congratulations, Laurine Idoux, Masters Student from University of Paris, completed studies on oxygen-dependent cancer metabolism and role in metastasis, working closely with and mentored by Daphne Superville.
New Grant: September, 2024 - Excited to start work on a newly funded NIH R01 (MPI) with Dr. Nimmi Ramanujam and her team. Goal is to develop technology for improved spatial analysis of cancer metabolism.